A Phase 1, Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of TAK-272 and the Effect of TAK-272 on the Pharmacokinetics of Digoxin or Midazolam In the Healthy Adult Participants

Trial Profile

A Phase 1, Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of TAK-272 and the Effect of TAK-272 on the Pharmacokinetics of Digoxin or Midazolam In the Healthy Adult Participants

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Nov 2016

At a glance

  • Drugs TAK 272 (Primary) ; Digoxin; Itraconazole; Midazolam
  • Indications Diabetic nephropathies; Hypertension
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Takeda
  • Most Recent Events

    • 29 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 08 Jun 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record..
    • 08 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Apr 2016 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top